United Therapeutics (NASDAQ:UTHR) falls sharply after disclosing its late-stage drug for pulmonary arterial hypertension failed to improving walking distance for patients. The firm says it will still move forward to seek FDA approval based on an earlier positive study. Shares down 21% premarket.
United Therapeutics (NASDAQ:UTHR) falls sharply after disclosing its late-stage drug for...
Recommended For You
More Trending News
About UTHR Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| UTHR | - | - |
| United Therapeutics Corporation | ||